Recombinant Human Anti-DENV x Human Anti-CD64 Bispecific Antibody (scIgG) (SCIGG-H316)

Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-DENV and anti-CD64 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget neutrophils cells to dengue virus. It is designed for the research of Dengue virus infection therapy.

Datasheet INQUIRY

Specifications

Targets

DENV & CD64

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Dengue virus infection

Targets

Target 1

DENV

Alternative Names

dengue virus; DENV; dengue fever; Flavivirus

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-DENV x Human Anti-CD64 Bispecific Antibody (scIgG) (SCIGG-H316). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-DENV x Human Anti-CD64 Bispecific Antibody (scIgG) (CAT#: SCIGG-H316)

Specifications

Targets

Customer Reviews and Q&As